CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
Protalix Biotherapeutics is a biopharmaceutical company that is focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary ProCellEx plant cell-based protein expression system. U...Show all
Company (IPO / Went public)
Phone: +972-4-902-8100
2 Snunit St., Science Park
POB 455
Carmiel, 20100
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells | Sep 07, 2011 | Aug 15, 2017 | Patent |
| Stabilized alpha-galactosidase and uses thereof | Nov 10, 2015 | Jul 18, 2017 | Patent |
| Dry powder formulations of dnase i | Jan 31, 2013 | Mar 28, 2017 | Patent |
| Inhalable liquid formulations of dnase i | Jan 31, 2013 | Mar 28, 2017 | Patent |
| Plant cell culture expressing human lysosomal proteins and uses thereof | Jun 02, 2014 | Dec 29, 2015 | Patent |
